Aardvark Therapeutics, Inc. (AARD)

NASDAQ: AARD · Real-Time Price · USD

7.25

+0.37 (5.38%)

Aug 25, 2026, 4:00 PM EDT - Market closed

Aardvark Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	73.85	47.05	61.64	9.74	15.56
Short-Term Investments	0.02	62.98	12.02	0.25	0.55
Cash & Short-Term Investments	73.87	110.03	73.66	9.99	16.11
Cash Growth	-47.91%	49.36%	637.44%	-37.98%	-
Prepaid Expenses	5.61	1.86	0.47	0.25	0.32
Other Current Assets	1.18	-	-	0.13	0.07
Total Current Assets	80.66	111.89	74.14	10.37	16.49
Property, Plant & Equipment	0.63	0.36	0.74	0.16	0.25
Other Long-Term Assets	0.17	4.94	2.64	0.01	0.01
Total Assets	81.46	117.18	77.51	10.54	16.76

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	2.09	2.07	2.3	1.04	0.26
Accrued Expenses	3.9	8.04	2.29	0.24	0.24
Current Portion of Leases	0.4	0.44	0.34	0.11	0.1
Total Current Liabilities	6.39	10.55	4.93	1.38	0.6
Long-Term Leases	0.28	-	0.44	0.05	0.16
Other Long-Term Liabilities	-	-	0.03	0	0.02
Total Liabilities	6.66	10.55	5.39	1.43	0.78

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Additional Paid-In Capital	226.69	222.47	3.68	2.94	2.61
Retained Earnings	-151.89	-115.92	-58.33	-37.74	-30.53
Comprehensive Income & Other	-	0.08	-	-	-
Total Common Equity	74.8	106.63	-54.64	-34.8	-27.92
Shareholders' Equity	74.8	106.63	72.11	9.1	15.98
Total Liabilities & Equity	81.46	117.18	77.51	10.54	16.76

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	0.68	0.44	0.78	0.16	0.26
Net Cash (Debt)	73.19	109.59	72.88	9.83	15.84
Net Cash Growth	-48.15%	50.36%	641.67%	-37.97%	-
Net Cash Per Share	3.36	5.58	18.24	2.48	4.07
Filing Date Shares Outstanding	21.88	21.82	21.7	3.97	3.89
Total Common Shares Outstanding	21.88	21.82	4.07	3.97	3.89
Working Capital	74.27	101.34	69.21	8.99	15.9
Book Value Per Share	3.42	4.89	-13.44	-8.77	-7.18
Tangible Book Value	74.8	106.63	-54.64	-34.8	-27.92
Tangible Book Value Per Share	3.42	4.89	-13.44	-8.77	-7.18

SEC Filings: 10-K · 10-Q